Insider Transactions in Q3 2023 at Glycomimetics Inc (GLYC)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2023
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
9,167
+38.87%
|
$9,167
$1.5 P/Share
|
|
Sep 30
2023
|
Rachel K. King |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+1.3%
|
$6,667
$1.5 P/Share
|
|
Sep 30
2023
|
Patricia S Andrews |
BUY
Grant, award, or other acquisition
|
Direct |
8,167
+13.26%
|
$8,167
$1.5 P/Share
|
|
Sep 22
2023
|
Edwin Rock Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
30,403
+7.49%
|
$30,403
$1.38 P/Share
|
|
Sep 21
2023
|
Edwin Rock Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
35,000
+9.21%
|
$35,000
$1.38 P/Share
|